Group 1 - The company has revised its Articles of Association, Shareholders' Meeting Rules, and Board Meeting Rules, and has decided to abolish the Supervisory Board [1][2][3] - The revisions are in accordance with the new Company Law effective from July 1, 2024, and other relevant regulations [2][3] - Key changes include renaming the Shareholders' Meeting Rules, clarifying decision-making authority, and transferring the powers of the Supervisory Board to the Audit Committee [2][3][4] Group 2 - The decision to abolish the Supervisory Board aims to enhance corporate governance and streamline operations [3][4] - The current Supervisory Board members will be dismissed upon approval by the shareholders' meeting, while they will continue to fulfill their duties until then [3][4] - The company expresses gratitude for the contributions made by the Supervisory Board and its members during their tenure [3]
白云山: 广州白云山医药集团股份有限公司关于修订《公司章程》《股东大会议事规则》及《董事会议事规则》相关条款并取消监事会的公告